Browsing Tag
Tarapur
4 posts
Bajaj Healthcare (NSE: BAJAJHCARE) rallies 16% on Cenobamate approval milestone
BAJAJHCARE surged on India’s first Cenobamate recommendation. Final approval and launch economics must now justify the ₹1,183 crore valuation.
Orient Press Q4 FY26 results: Is #ORIENTLTD finally showing signs of a packaging turnaround?
Orient Press Limited narrowed FY26 losses and swung to Q4 profit, but revenue pressure remains. Read what #ORIENTLTD investors should watch next.
Aarti Drugs soars with Q4 FY25 profit spike—But what’s behind the full-year revenue drop?
Aarti Drugs Q4 FY25 profit rose 33% YoY as exports rebounded, but full-year revenue declined 5%. See what’s behind the surge—and the challenges ahead.
Aarti Drugs launches dermatology product production at new Tarapur facility
Aarti Drugs Limited (NSE: AARTIDRUGS; BSE:524348), a Mumbai-based pharmaceutical powerhouse, has officially announced the start of its dermatology…